Patent · US Active

Epinephrine spray formulations

US11771663B2 · kind B2 · utility

0Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 2, 2021
Grant dateOct 3, 2023
Priority date
Expiry dateJul 30, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to epinephrine spray formulations. The present invention is further directed to methods of treating anaphylaxis by administering epinephrine spray formulations to subjects in need of such treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.